TrialBMC cancer2021

Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial.

Ting Martin Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.